Abstract
BACKGROUND Huntington’s disease (HD) is an inherited, neurodegenerative disorder, caused by the expansion of an unstable CAG repeat sequence in the HTT gene. The prevalence of HD, allelic diversity, rate of novel expansions, and the clinical correlates, vary across populations.
OBJECTIVE We aimed to analyze the diversity of alleles, and their clinical correlates; and describe the mode of inheritance and the pattern of instability of CAG repeats in a few families
METHODS Clinical history and pedigree structure were collected from clinical records, or through interviews between 2016-19. Genetic testing at the HD locus was done on clinical suspicion, or relatedness, after counseling. Descriptive statistics and correlation analysis were used.
RESULTS Expanded repeats were detected in 239 individuals, including 232 who were symptomatic, and seven presymptomatic relatives. The number of CAG repeats (mean=45.6) and age at onset (AAO) (mean=39.2 years) showed a strong inverse correlation (r=-0.67). We found atypical alleles such as 8 intermediate alleles (IA), 12 reduced penetrance alleles (RPA) and 14 large (>60) expansion alleles corresponding to juvenile HD. Three individuals carried biallelic expansions. Paternal inheritance was more common and the mean increase in repeats in the available parent-child pairs was 14. Thirty-seven individuals had no family history of HD, of which a de novo expansion could be ascertained in 3 cases.
CONCLUSIONS Novel mutations at HTT locus may not be rare in India. A lack of family history should not exclude appropriate testing. Prevalence of intermediate alleles and incidence of de novo expansions, suggests that there may be a reservoir of alleles prone to expansion.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr Nikhil Ratna is funded by Indian Council of Medical research for the doctoral work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by Institute Ethics Committee - National Institute of Mental Health and Neurosciences(Ref No. NIMH/DO/ETHICS SUB-COMMITTEE 29th MEETING/2016).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos